Genetic deficiencies or mutations in Drp1 result in pronounced mitochondrial anomalies, which are associated with severe neurodevelopmental delay.4–6 Conversely, enhancement of Drp1 activity is implicated in neurodegenerative disorders such as Parkinson’s, Alzheimer’s, and Huntington’s disease.7–9. Here, DNM1L is linked to Parkinson disease.